119 related articles for article (PubMed ID: 12604215)
1. The high resolution crystal structure of rat liver AKR7A1: understanding the substrate specificites of the AKR7 family.
Kozma E; Brown E; Ellis EM; Lapthorn AJ
Chem Biol Interact; 2003 Feb; 143-144():289-97. PubMed ID: 12604215
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of rat liver AKR7A1. A dimeric member of the aldo-keto reductase superfamily.
Kozma E; Brown E; Ellis EM; Lapthorn AJ
J Biol Chem; 2002 May; 277(18):16285-93. PubMed ID: 11839745
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of mouse succinic semialdehyde reductase AKR7A5: structural basis for substrate specificity.
Zhu X; Lapthorn AJ; Ellis EM
Biochemistry; 2006 Feb; 45(6):1562-70. PubMed ID: 16460003
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning, expression and catalytic activity of a human AKR7 member of the aldo-keto reductase superfamily: evidence that the major 2-carboxybenzaldehyde reductase from human liver is a homologue of rat aflatoxin B1-aldehyde reductase.
Ireland LS; Harrison DJ; Neal GE; Hayes JD
Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):21-34. PubMed ID: 9576847
[TBL] [Abstract][Full Text] [Related]
5. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of a novel mouse liver aldo-keto reductase AKR7A5.
Hinshelwood A; McGarvie G; Ellis E
FEBS Lett; 2002 Jul; 523(1-3):213-8. PubMed ID: 12123834
[TBL] [Abstract][Full Text] [Related]
7. Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins.
Kelly VP; Sherratt PJ; Crouch DH; Hayes JD
Biochem J; 2002 Sep; 366(Pt 3):847-61. PubMed ID: 12071861
[TBL] [Abstract][Full Text] [Related]
8. Trp266 determines the binding specificity of a porcine aflatoxin B₁ aldehyde reductase for aflatoxin B₁-dialdehyde.
Wu J; Xu W; Zhang C; Chang Q; Tang X; Li K; Deng Y
Biochem Pharmacol; 2013 Nov; 86(9):1357-65. PubMed ID: 24008121
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of an aldehyde reductase Y50F mutant-NADP complex and its implications for substrate binding.
Ye Q; Hyndman D; Green NC; Li L; Jia Z; Flynn TG
Chem Biol Interact; 2001 Jan; 130-132(1-3):651-8. PubMed ID: 11306083
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
Knight LP; Primiano T; Groopman JD; Kensler TW; Sutter TR
Carcinogenesis; 1999 Jul; 20(7):1215-23. PubMed ID: 10383892
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of yeast xylose reductase in complex with a novel NADP-DTT adduct provides insights into substrate recognition and catalysis.
Paidimuddala B; Mohapatra SB; Gummadi SN; Manoj N
FEBS J; 2018 Dec; 285(23):4445-4464. PubMed ID: 30269423
[TBL] [Abstract][Full Text] [Related]
12. Purification from rat liver of a novel constitutively expressed member of the aldo-keto reductase 7 family that is widely distributed in extrahepatic tissues.
Kelly VP; Ireland LS; Ellis EM; Hayes JD
Biochem J; 2000 Jun; 348 Pt 2(Pt 2):389-400. PubMed ID: 10816434
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of 3 alpha-hydroxysteroid dehydrogenase.
Penning TM; Bennett MJ; Smith-Hoog S; Schlegel BP; Jez JM; Lewis M
Steroids; 1997 Jan; 62(1):101-11. PubMed ID: 9029723
[TBL] [Abstract][Full Text] [Related]
14. Aldo-keto reductases 7A subfamily: A mini review.
Zhao M; Chen J; Chen H; Zhang J; Li D
Chem Biol Interact; 2024 Mar; 391():110896. PubMed ID: 38301882
[TBL] [Abstract][Full Text] [Related]
15. The aldo-keto reductase superfamily homepage.
Hyndman D; Bauman DR; Heredia VV; Penning TM
Chem Biol Interact; 2003 Feb; 143-144():621-31. PubMed ID: 12604248
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of an aflatoxin-metabolizing aldehyde reductase.
Ellis EM; Hayes JD
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):535-41. PubMed ID: 8526867
[TBL] [Abstract][Full Text] [Related]
17. Probing the substrate binding site of Candida tenuis xylose reductase (AKR2B5) with site-directed mutagenesis.
Kratzer R; Leitgeb S; Wilson DK; Nidetzky B
Biochem J; 2006 Jan; 393(Pt 1):51-8. PubMed ID: 16336198
[TBL] [Abstract][Full Text] [Related]
18. Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.
Roebuck BD; Johnson DN; Sutter CH; Egner PA; Scholl PF; Friesen MD; Baumgartner KJ; Ware NM; Bodreddigari S; Groopman JD; Kensler TW; Sutter TR
Toxicol Sci; 2009 May; 109(1):41-9. PubMed ID: 19168568
[TBL] [Abstract][Full Text] [Related]
19. An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.
Ellis EM; Judah DJ; Neal GE; Hayes JD
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10350-4. PubMed ID: 8234296
[TBL] [Abstract][Full Text] [Related]
20. Resistance to aflatoxin B1 is associated with the expression of a novel aldo-keto reductase which has catalytic activity towards a cytotoxic aldehyde-containing metabolite of the toxin.
Hayes JD; Judah DJ; Neal GE
Cancer Res; 1993 Sep; 53(17):3887-94. PubMed ID: 8395332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
